80 related articles for article (PubMed ID: 33221504)
21. MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients.
Arosio A; Sala G; Rodriguez-Menendez V; Grana D; Gerardi F; Lunetta C; Ferrarese C; Tremolizzo L
Mol Cell Neurosci; 2016 Jul; 74():10-7. PubMed ID: 26921792
[TBL] [Abstract][Full Text] [Related]
22. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
23. MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma/leukemia.
Sun J; Yu W; Zhang X
Ann Hematol; 2020 Jan; 99(1):185-188. PubMed ID: 31781846
[No Abstract] [Full Text] [Related]
24. Crystallization and preliminary X-ray analysis of the Pax6 paired domain bound to the Pax6 gene enhancer.
Ito M; Oyama T; Okazaki K; Morikawa K
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Nov; 61(Pt 11):1009-12. PubMed ID: 16511221
[TBL] [Abstract][Full Text] [Related]
25. The involvement of myocyte enhancer factor 2D in regulating tumor biology of cardiac myxoma.
Huo Y; Zhao Q; Wang C; Zhao F; Du Y; Sun W
Tumour Biol; 2016 Apr; 37(4):5405-11. PubMed ID: 26563368
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a novel
Van Outersterp I; Hormann FM; Hoogkamer AQ; Boeree A; Van den Broek SA; Den Boer ML; Boer JM
Haematologica; 2023 Oct; 108(10):2859-2864. PubMed ID: 37051743
[No Abstract] [Full Text] [Related]
27. A myocyte enhancer factor 2D (MEF2D) kinase activated during neuronal apoptosis is a novel target inhibited by lithium.
Linseman DA; Cornejo BJ; Le SS; Meintzer MK; Laessig TA; Bouchard RJ; Heidenreich KA
J Neurochem; 2003 Jun; 85(6):1488-99. PubMed ID: 12787068
[TBL] [Abstract][Full Text] [Related]
28. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B.
Guo B; Hu S; Zheng C; Wang H; Luo F; Li H; Cui W; Yang X; Cui G; Mak S; Choi TC; Ma ED; Wang Y; Lee SMY; Zhang Z; Han Y
Neuropharmacology; 2017 Nov; 126():12-24. PubMed ID: 28807675
[TBL] [Abstract][Full Text] [Related]
29. Neuronal Myocyte-Specific Enhancer Factor 2D (MEF2D) Is Required for Normal Circadian and Sleep Behavior in Mice.
Mohawk JA; Cox KH; Sato M; Yoo SH; Yanagisawa M; Olson EN; Takahashi JS
J Neurosci; 2019 Oct; 39(40):7958-7967. PubMed ID: 31420455
[TBL] [Abstract][Full Text] [Related]
30. FAK Forms a Complex with MEF2 to Couple Biomechanical Signaling to Transcription in Cardiomyocytes.
Cardoso AC; Pereira AHM; Ambrosio ALB; Consonni SR; Rocha de Oliveira R; Bajgelman MC; Dias SMG; Franchini KG
Structure; 2016 Aug; 24(8):1301-1310. PubMed ID: 27427476
[TBL] [Abstract][Full Text] [Related]
31. Crystal Structure of Apo MEF2B Reveals New Insights in DNA Binding and Cofactor Interaction.
Lei X; Shi H; Kou Y; Rajashekar N; Wu F; Sen C; Xu J; Chen L
Biochemistry; 2018 Jul; 57(28):4047-4051. PubMed ID: 29944822
[TBL] [Abstract][Full Text] [Related]
32. Overexpression, purification and preliminary X-ray analysis of pullulanase from Bacillus subtilis strain 168.
Malle D; Itoh T; Hashimoto W; Murata K; Utsumi S; Mikami B
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Apr; 62(Pt 4):381-4. PubMed ID: 16582490
[TBL] [Abstract][Full Text] [Related]
33. Purification, crystallization, and preliminary x-ray diffraction studies of tRNA-guanine transglycosylase from Zymomonas mobilis.
Romier C; Ficner R; Reuter K; Suck D
Proteins; 1996 Apr; 24(4):516-9. PubMed ID: 8860000
[TBL] [Abstract][Full Text] [Related]
34. Myocyte enhancer factor 2D provides a cross-talk between chronic inflammation and lung cancer.
Zhu HX; Shi L; Zhang Y; Zhu YC; Bai CX; Wang XD; Zhou JB
J Transl Med; 2017 Mar; 15(1):65. PubMed ID: 28340574
[TBL] [Abstract][Full Text] [Related]
35. MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma.
Wang W; Chen LC; Qian JY; Zhang Q
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9829-9839. PubMed ID: 31799650
[TBL] [Abstract][Full Text] [Related]
36. Expression, purification and crystallization of a novel nonstructural protein VP9 from white spot syndrome virus.
Liu Y; Sivaraman J; Hew CL
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Aug; 62(Pt 8):802-4. PubMed ID: 16880562
[TBL] [Abstract][Full Text] [Related]
37. Crystallization and preliminary X-ray diffraction analysis of a chitin-binding domain of hyperthermophilic chitinase from Pyrococcus furiosus.
Nakamura T; Ishikawa K; Hagihara Y; Oku T; Nakagawa A; Inoue T; Ataka M; Uegaki K
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 May; 61(Pt 5):476-8. PubMed ID: 16511072
[TBL] [Abstract][Full Text] [Related]
38. Purification, crystallization and preliminary X-ray analysis of rice BGlu1 beta-glucosidase with and without 2-deoxy-2-fluoro-beta-D-glucoside.
Chuenchor W; Pengthaisong S; Yuvaniyama J; Opassiri R; Svasti J; Ketudat Cairns JR
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Aug; 62(Pt 8):798-801. PubMed ID: 16880561
[TBL] [Abstract][Full Text] [Related]
39. Purification, characterization and crystallization of recombinant HIV-1 reverse transcriptase.
Bhikhabhai R; Joelson T; Unge T; Strandberg B; Carlsson T; Lövgren S
J Chromatogr; 1992 Jun; 604(1):157-70. PubMed ID: 1379251
[TBL] [Abstract][Full Text] [Related]
40. Expression, purification, crystallization and preliminary crystal structure analysis of the Deinococcus radiodurans organic hydroperoxide-resistance protein.
Meunier-Jamin C; Kapp U; Leonard G; McSweeney S
Acta Crystallogr D Biol Crystallogr; 2004 May; 60(Pt 5):920-2. PubMed ID: 15103139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
